Alignment Healthcare (NASDAQ: ALHC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Alignment Healthcare reported 78 open-market sales of 27,970,603 shares ($517.7m) and 1 open-market purchase of 14,848 shares ($197,627), by 12 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 6 October 2026 | Kim Hyong | Chief Medical Officer | Open-market sale | −32,479 | $8.30 | 299,271 | Form 4 |
| 17 September 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Open-market sale | −23,511 | $8.61 | 1,080,305 | Form 4 |
| 14 September 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −27,400 | $13.00 | 590,766 | Form 4 |
| 11 September 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −385,270 | $12.68 | 1,223,473 | Form 4 |
| 11 September 2026 | Maroney Dawn Christine | President | Open-market sale | −122,707 | $12.68 | 794,606 | Form 4 |
| 10 September 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −172,600 | $12.96 | 618,166 | Form 4 |
| 14 August 2026 | Maroney Dawn Christine | President | Open-market sale, 10b5-1 plan | −5,000 | $14.00 | 917,313 | Form 4 |
| 10 August 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −298,000 | $13.88 | 790,766 | Form 4 |
| 15 July 2026 | Maroney Dawn Christine | President | Option exercise, 10b5-1 plan | +152,068 | $9.06 | 1,099,381 | Form 4 |
| 15 July 2026 | Maroney Dawn Christine | President | Open-market sale, 10b5-1 plan | −177,068 | $20.83 | 922,313 | Form 4 |
| 10 July 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −279,644 | $19.81 | 1,107,122 | Form 4 |
| 10 July 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −18,356 | $20.65 | 1,088,766 | Form 4 |
| 1 July 2026 | Hochradel Shane J. | Chief Operations Officer | Grant or award | +87,719 | — | 87,719 | Form 4 |
| 1 July 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Open-market sale, 10b5-1 plan | −25,000 | $24.00 | 1,103,816 | Form 4 |
| 26 June 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Open-market sale, 10b5-1 plan | −25,000 | $23.00 | 1,128,816 | Form 4 |
| 18 June 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Open-market sale, 10b5-1 plan | −25,000 | $22.00 | 1,153,816 | Form 4 |
| 15 June 2026 | Maroney Dawn Christine | President | Open-market sale, 10b5-1 plan | −30,000 | $19.55 | 947,313 | Form 4 |
| 12 June 2026 | Kim Hyong | Chief Medical Officer | Open-market sale, 10b5-1 plan | −35,951 | $19.86 | 331,750 | Form 4 |
| 11 June 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Open-market sale, 10b5-1 plan | −25,000 | $21.00 | 1,178,816 | Form 4 |
| 10 June 2026 | Kao John E | Chief Executive Officer | Open-market sale, 10b5-1 plan | −74,936 | $19.65 | 1,609,830 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Alignment Healthcare page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.